Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Cobra India acquires 2.05% stake in Sakar Healthcare via open market - scanx.trade
Cobra India acquires 2.05% stake in Sakar Healthcare via open marketscanx.trade
Sakar Healthcare partners with Zydus Lifesciences for GCC Markets
Sakar Healthcare has partnered with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets. This marks the company's 40th global agreement in the anti-cancer segment. Sakar Healthcare is expanding its international oncology business and strengthening its presence in emerging markets. The company is also progressing with regulatory filings and approvals in highly regulated markets.
Multibagger healthcare stock retraces from near record high. Do you own?
Sakar Healthcare stock had touched a record high of ₹829.60 in the last trading session, while its 52-week low stands at ₹306, hit on 23 May last year. NSE data shows that 1.55 lakh shares of the healthcare firm were traded today.
Sakar Healthcare Q4 profit up 91% at Rs 11.02 crore
Sakar Healthcare announced strong financial results for the January-March quarter of 2025-26. Net profit surged by 91 percent to Rs 11.02 crore. Revenue from operations increased by 42 percent to Rs 71.09 crore. For the full fiscal year, net profit rose 74 percent to Rs 30.48 crore. Revenue jumped 42 percent to Rs 251.73 crore.
Stellar Wealth Partners India Fund acquires 0.87% stake in Sakar Healthcare, Zerodha Broking buys Rs 93 crore worth of Nazara Tech shares
Shares of Sakar Healthcare Limited may have reacted positively to the bulk deal, soaring 16.16 percent to end at a record closing high of Rs 696.7 amid strong volumes on the National Stock Exchange. Strong buying interest was also seen in Nazara Technologies Limited as its shares surged 12.76 percent to Rs 299.95.